Kwietniak Matthew R.'s Form 4 filing
Avid Bioservices, Inc. (CDMO) · filed Dec 27, 2024
- Accession no.
- 0001683168-24-009025
- Filed
- Dec 27, 2024
- Trade date
- Dec 25-26, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 10 derivative transactions. Open-market sales total $163.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kwietniak Matthew R.CIK 0001974519 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 25, 2024 | Common Stock, $0.001 par value | MOption exerciseAcquired | +9,300 | –F2 | – | 34,707 | Direct | |
| Dec 25, 2024 | Common Stock, $0.001 par value | MOption exerciseAcquired | +29,479 | –F3 | – | 64,186 | Direct | |
| Dec 26, 2024 | Common Stock, $0.001 par value | SSaleDisposed | −3,225 | $12.22 | −$39,409.5 | 60,961 | Direct | |
| Dec 26, 2024 | Common Stock, $0.001 par value | SSaleDisposed | −10,165 | $12.22 | −$124,216.3 | 50,796 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −1,005 | $0.00 | $0 | 74,107 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −1,893 | $0.00 | $0 | 72,214 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −1,908 | $0.00 | $0 | 70,306 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −4,494 | $0.00 | $0 | 65,812 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −6,725 | $0.00 | $0 | 130,568 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −6,725 | $0.00 | $0 | 123,843 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −6,782 | $0.00 | $0 | 117,061 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −6,782 | $0.00 | $0 | 110,279 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −15,972 | $0.00 | $0 | 94,307 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −15,972 | $0.00 | $0 | 78,335 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
Referenced by the price of 1 transaction in Table I.
- F3
Each performance stock unit ("PSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
Referenced by the price of 1 transaction in Table I.